1 / 4

Clinical Effectiveness & High Cost Drugs

Clinical Effectiveness & High Cost Drugs. Introduction from Roelof Konterman Vice-Chairman of the Executive Board & Head of Health, Achmea. Current Members. Background. Initially two separate Panels, which both first met in December 2015, as High Cost Drugs and New Medical Technologies

brooke
Download Presentation

Clinical Effectiveness & High Cost Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Effectiveness & High Cost Drugs Introduction from Roelof Konterman Vice-Chairman of the Executive Board & Head of Health, Achmea

  2. Current Members

  3. Background • Initially two separate Panels, which both first met in December 2015, as High Cost Drugs and New Medical Technologies • Now established as High Cost Drugs and Clinical Effectiveness, meeting at least once a year

  4. Current issues • Topics discussed include, but are not limited to: - Volume of treatments needed to improve patient outcomes - How to grade and access the merit of new and existing technologies - Establishing where there is benefit for knee arthroscopy - Gaining a better understanding of when and how to obtain better value from robotic surgery (Da Vinci) - Comparing outcomes between “at home” treatments vs traditional hospital settings - The impact of political advocacy & communication relating to High Cost Drugs - Reviewing the pipeline of High Cost Drugs entering the market

More Related